ReShape Lifesciences Inc. (RSLS)
0.67
-0.03 (-3.74%)
At close: Mar 21, 2025, 3:59 PM
-3.74% (1D)
| Bid | 0.62 |
| Market Cap | 2.2M |
| Revenue (ttm) | 53.15M |
| Net Income (ttm) | -45.9M |
| EPS (ttm) | 77.26 |
| PE Ratio (ttm) | 0.01 |
| Forward PE | -10.81 |
| Analyst | n/a |
| Ask | 0.75 |
| Volume | 116,840 |
| Avg. Volume (20D) | 1,168,135 |
| Open | 0.68 |
| Previous Close | 0.70 |
| Day's Range | 0.64 - 0.67 |
| 52-Week Range | 0.60 - 29.00 |
| Beta | 1.58 |
About RSLS
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investi...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 6, 2016
Employees 29
Stock Exchange NASDAQ
Ticker Symbol RSLS
1 month ago
-53.65%
ReShape Lifesciences shares are trading lower afte...
Unlock content with
Pro Subscription
4 months ago
-8.01%
ReShape Lifesciences shares are trading lower. The company reported Q3 financial results.
